 CRANBURY, N.J., June 09, 2021 GLOBE NEWSWIRE -- PMV Pharmaceuticals, Inc. Nasdaq: PMVP, a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President Chief Executive Officer, will present at the Bank of America Securities 2021 Napa Biopharma Virtual Conference on Monday, June 14th. 